However, CME ameliorated HFD increased food intake, body weight gain, hyperglycemia and dyslipidemia through normalization of HFD reduced leptin, adiponectin and UCP1 synthesis and production as well as its antioxidant activity suggesting that CME is a potent anti-obesity agent. The gene discussed is UCP1; the disease is Hyperglycemia.